Related references
Note: Only part of the references are listed.Possible involvement of TRPM2 activation in 5-fluorouracil-induced myelosuppression in mice
Masaaki Ishibashi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Inositol Hexakisphosphate and Inositol Enhance the Inhibition of Colorectal Cancer Growth and Liver Metastasis by Capecitabine in a Mouse Model
Chunlei Li et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
Doxifluridine-based pharmacosomes delivering miR-122 as tumor microenvironments-activated nanoplatforms for synergistic treatment of hepatocellular carcinoma
Fangqin Xue et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling
Hui Liu et al.
CELL DEATH & DISEASE (2021)
B cells as antigen-presenting cells in transplantation rejection and tolerance
Anita S. Chong
CELLULAR IMMUNOLOGY (2020)
Liver transplantation. Current aspects of pretransplantation diagnosis and rejection
Hideo A. Baba et al.
PATHOLOGE (2020)
The Immunological Basis of Liver Allograft Rejection
Vincenzo Ronca et al.
FRONTIERS IN IMMUNOLOGY (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
IL-10-producing T cells and their dual functions
Tanja Bedke et al.
SEMINARS IN IMMUNOLOGY (2019)
PERK/eIF-2α/CHOP Pathway Dependent ROS Generation Mediates Butein-induced Non-small-cell Lung Cancer Apoptosis and G2/M Phase Arrest
Shouyin Di et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
David M. Peereboom et al.
JCI INSIGHT (2019)
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
Franco Trevisani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Interleukin-6 Family Cytokines
Stefan Rose-John
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
Stefania Orecchioni et al.
BRITISH JOURNAL OF CANCER (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Human T Cell Development, Localization, and Function throughout Life
Brahma V. Kumar et al.
IMMUNITY (2018)
Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients
Teresa Di Desidero et al.
INVESTIGATIONAL NEW DRUGS (2018)
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept
Stefania De Lorenzo et al.
SCIENTIFIC REPORTS (2018)
The Balance of Th1/Th2 and LAP+Tregs/Th17 Cells Is Crucial for Graft Survival in Allogeneic Corneal Transplantation
Shang Li et al.
JOURNAL OF OPHTHALMOLOGY (2018)
Regulation of T cell immunity by cellular metabolism
Zhilin Hu et al.
FRONTIERS OF MEDICINE (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Population Pharmacokinetic-Pharmacodynamic Modeling of 5-Fluorouracil for Toxicities in Rats
Shinji Kobuchi et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2017)
Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation
Tiffany C. L. Wong et al.
EXPERT OPINION ON EMERGING DRUGS (2017)
Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy
Yin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells
Huiying Zhao et al.
CANCER MEDICINE (2017)
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
Andrea Casadei Gardini et al.
SCIENTIFIC REPORTS (2017)
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation
Matteo Ravaioli et al.
SCIENTIFIC REPORTS (2017)
Enhanced B Cell Alloantigen Presentation and Its Epigenetic Dysregulation in Liver Transplant Rejection
M. Ningappa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats
Yang Yang et al.
STEM CELL RESEARCH & THERAPY (2016)
The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients
Liang Ma et al.
BMC IMMUNOLOGY (2015)
Low percentage of CD24hiCD27+CD19+ B cells decelerates gastric cancer progression in XELOX-treated patients
Jiao Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Hematopoiesis in 5-Fluorouracil-Treated Adenosine A3 Receptor Knock-Out Mice
M. Hofer et al.
PHYSIOLOGICAL RESEARCH (2015)
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature
Alberto Bongiovanni et al.
ONCOTARGETS AND THERAPY (2014)
Possible Involvement of Oxidative Stress in 5-Fluorouracil-Mediated Myelosuppression in Mice
Satoshi Numazawa et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
The regulation of IL-10 production by immune cells
Margarida Saraiva et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection
AC Allison et al.
TRANSPLANTATION (2005)
Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis
Y Hashimoto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Clinical pharmacokinetics of capecitabine
B Reigner et al.
CLINICAL PHARMACOKINETICS (2001)
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
J Schüller et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)